Drug Trial Radar · NCT07771465
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
332
Planned (sponsor's estimate)
Start
Aug 26, 2026
Primary completion
Nov 2032
Study completion Jan 2033
Sponsor
- Lead sponsor
- Kardigan, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Danicamtiv is an investigational medication, which means it is still being studied and has not been approved. The purpose of this study is to learn how well danicamtiv works, how safe it is, how well people can take it when used in patients with genetic or familial dilated cardiomyopathy (DCM). There are currently no approved medicines made specifically to treat genetic or familial DCM.
Conditions
- Symptomatic Genetic Dilated Cardiomyopathy (DCM)
Interventions
DanicamtivDrug
Danicamtiv will be administered twice daily for up to 5 years
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency and severity of treatment-emergent adverse events (TEAEs)Time frame: 61 months
- Frequency and severity of adverse events of special interest (AESIs)Time frame: 61 months
- Frequency and severity of serious adverse events (SAEs)Time frame: 61 months
- Frequency and severity of disease-related events (DREs)Time frame: 61 months
- Frequency of abnormal findings from physical examinationTime frame: 61 months
- Frequency of abnormal findings from vital signsTime frame: 61 months
- Frequency of abnormal findings from 12-lead electrocardiograms (ECGs)Time frame: 61 months
- Frequency of abnormal findings from clinical laboratory assessmentsTime frame: 61 months
Locations
78 sites in 11 countries. Site status is shown where the registry gives one.
University of Alabama Birmingham
Birmingham, Alabama · Recruiting
Cedars Sinai
Los Angeles, California · Recruiting
University of California, Los Angeles (UCLA) - David Geffen School of Medicine
Los Angeles, California · Not yet recruiting
University of California, San Diego (UCSD) - Medical Center
San Diego, California · Not yet recruiting
University of California, San Francisco (UCSF)
San Francisco, California · Not yet recruiting
Stanford University Medical Center
Stanford, California · Not yet recruiting
MedStar Washington Hospital Center
Washington D.C., District of Columbia · Recruiting
Mayo Clinic - Jacksonville
Jacksonville, Florida · Not yet recruiting
Northwestern University
Chicago, Illinois · Not yet recruiting
Louisiana State University (LSU) Health Sciences Center
New Orleans, Louisiana · Not yet recruiting
Johns Hopkins Medicine
Baltimore, Maryland · Not yet recruiting
Brigham and Women's Hospital
Boston, Massachusetts · Recruiting
Henry Ford Health System
Detroit, Michigan · Not yet recruiting
University of Minnesota
Minneapolis, Minnesota · Not yet recruiting
Mayo Clinic - Rochester
Rochester, Minnesota · Not yet recruiting
Saint Luke's Mid America Heart Institute
Kansas City, Missouri · Not yet recruiting
Washington University in St. Louis
St Louis, Missouri · Recruiting
University of Nebraska Medical Center
Omaha, Nebraska · Not yet recruiting
NYU Langone Health
New York, New York · Not yet recruiting
Columbia University Medical Center/ New York Presbyterian Hospital
New York, New York · Not yet recruiting
Duke University Medical Center
Durham, North Carolina · Not yet recruiting
The Lindner Center for Research and Education at The Christ Hospital
Cincinnati, Ohio · Not yet recruiting
The Ohio State University Wexner Medical Center
Columbus, Ohio · Recruiting
Oregon Health & Science University (OHSU)
Portland, Oregon · Not yet recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Not yet recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Not yet recruiting
Baylor College of Medicine
Houston, Texas · Not yet recruiting
Houston Methodist Hospital
Houston, Texas · Not yet recruiting
AZORG - Campus Moorselbaan
Aalst, Belgium · Not yet recruiting
Universite Libre de Bruxelles (ULB) - Hopital Erasme
Brussels, Belgium · Not yet recruiting
Universitair Ziekenhuis Antwerpen (UZA)
Edegem, Belgium · Not yet recruiting
Jessa Ziekenhuis
Hasselt, Belgium · Not yet recruiting
UZ Leuven
Leuven, Belgium · Not yet recruiting
Aarhus University Hospital
Aarhus, Denmark · Recruiting
Rigshospitalet
Copenhagen, Denmark · Not yet recruiting
Odense University Hospital - Odense
Odense, Denmark · Not yet recruiting
CHRU de Tours - Hopital Trousseau
Chambray-lès-Tours, France · Not yet recruiting
CHU de Lille - Institut Coeur Poumon
Lille, France · Not yet recruiting
AP-HP Hopital Pitie-Salpetriere
Paris, France · Not yet recruiting
AP-HP Hopital Europeen Georges Pompidou
Paris, France · Not yet recruiting
Showing 40 of 78 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.